CLASS II ONGOING Device recall · Reported 15 Jul 2026 · FDA Enforcement Report

Vitek 2 Ast-N447 Test Kit Product reference recalled by Biomerieux

Biomerieux is recalling Vitek 2 Ast-N447 Test Kit Product reference 424620. The recall was initiated on 4 Jun 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot 0853293604 UDI-DI 03573026634551 Product is not registered in the US. OUS only.
Quantity recalled45,900 cards

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2715-2026
FDA event ID
99213
Recalling firm
Biomerieux, Hazelwood, MO
Classification
Class II
Status
Ongoing
Recall initiated
4 Jun 2026
FDA classified
9 Jul 2026
Reported
15 Jul 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

4 Jun 2026Recall initiated by company
9 Jul 2026Classified by FDA+35 days
15 Jul 2026Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures.

Product as listed by the FDA

VITEK 2 AST-N447 TEST KIT Product reference 424620

Where it was distributed

International distribution to the countries of Belgium and the Netherlands.

Questions about this recall

Why was it recalled?

Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures.

Which lots are affected?

Lot 0853293604 UDI-DI 03573026634551 Product is not registered in the US. OUS only.

Where was it sold?

International distribution to the countries of Belgium and the Netherlands.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Biomerieux

All 476

Other Test Kits & Diagnostics recalls

All 2,656